Skip to content

Testing a Scalable Model For ACEs-Related Care Navigation

Testing a Scalable Model For ACEs-Related Care Navigation Via 211 Telephone-Based Services

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05567250
Enrollment
102
Registered
2022-10-05
Start date
2022-10-05
Completion date
2023-11-24
Last updated
2024-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Childhood Experiences, Child Development

Keywords

Health Services Research, Care Coordination

Brief summary

The study is a randomized controlled trial of a telephone-based care coordination system for families who experienced Adverse Childhood Events (ACEs). The investigators will conduct the study in partnership with Kaiser Permanente School of Medicine (KPSOM) and 2-1-1 Los Angeles County (211LA), part of a national network of 2-1-1 call centers covering 93% of the US population. The study will test the effectiveness of 211LA in increasing referrals and services for families who screen positive for ACEs.

Detailed description

The trial will enroll 200 children ages 0-11 years from the three FQHCs partner clinics, who screen positive for at least 1 ACE during their clinical encounter. The research study team will randomize children 1:1 into intervention (connection to 211LA for ACEs care coordination + usual care) or control (usual care alone). Primary outcomes will include number of referrals to, eligibility for, and receipt of ACE-related services among intervention group participants compared to controls. The investigators will measure these outcomes through parent reported data and 211LA data at baseline and 6 months after enrollment. Expected findings include higher referral and service rates by six months after enrollment among intervention group participants.

Interventions

BEHAVIORALBehavioral: Telephone-based ACEs care coordination

The 211LA care coordinator will use the agency's extensive resource directory to identify and provide appropriate referral recommendations to each family. In addition, they will develop a care coordination plan, noting these recommendations and plans for follow-up, to be provided to the family's clinical care provider. The coordinator will routinely follow-up with the family until 1) children begin receiving services, 2) families refuse services, or 3) children are deemed ineligible by service providers.

Sponsors

Kaiser Permanente School of Medicine
CollaboratorOTHER
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* A patient in one of the three partner community clinic systems (ChapCare, Via Care and NEVHC) * Child aged 0 - 11 years old * Parent or legal guardian of child at least 18 years of age * Comfortable completing a survey by interview in English or Spanish

Exclusion criteria

* Child or sibling already enrolled in this study * Child or sibling enrolled in the AMP Child Development study

Design outcomes

Primary

MeasureTime frameDescription
Referrals to ACEs-related services2-6 months after enrollmentThe percentage of children who are referred to at least one ACEs-related service, as reported on the participant survey.

Secondary

MeasureTime frameDescription
Receipt of ACEs-related services2-6 months after enrollmentThe percentage of children who receive at least one ACEs-related service, as reported on the participant survey.
Number of referrals received2-6 months after enrollmentThe number of referrals made for ACEs-related services, as reported on the participant survey.
Number of services received2-6 months after enrollmentThe number of ACEs-related services received, as reported on the participant survey.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026